Patent Expiry
RPRX: AMVUTTRA: recorded patent 11286486 expiry
July 28, 2036 · VUTRISIRAN SODIUM. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- July 28, 2036
- Company
- Royalty Pharma plc (RPRX)
- Drug
- VUTRISIRAN SODIUM
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Patent Expiry
AMVUTTRA: recorded patent 11286486 expiry
Orange Book application NDA215515, product 001, listed patent 11286486 expiry. Overall loss of exclusivity and current company rights: unknown.FDA source
- Company
- Royalty Pharma plc (RPRX)